Introduction
A significant cause of ischemic stroke is from intracranial atherosclerotic disease due either to hypoperfusion or distal embolization. The incidence has been reported to be 6-10% in whites, 6-22% in blacks, 11% in hispanics, and 11-22% in the oriental population. The prognosis and morbidity rate for patients with intracranial stenosis varies widely from 10-46%
per year, independent of medical therapy" The surgical option of an extracranial to intracranial bypass procedure has not been show to be of significant benefit over best medical therapy for these patients".
Over More recently, several centers have reported upon use of intracranial stents for these lesions. Mori et al, reported upon 10 patients with 12 intracranial atherosclerotic lesions. They reported an 80% technical success rate in accessing the lesion with a stent, and in those patients that were stented, there were no periprocedural complications and there was significant im- has not yet been determined for these patients, extrapolation from the extracranial circulation for carotid atherosclerotic disease, does indicate that if a direct surgical or endovascular revascularization procedure can be performed within acceptable technical success rates (ie : low periprocedural complication rates, than it may be better than medical therapy in certain types of patients. Clearly, once patients have failed medical therapy with anti-platelet and/or anticoagulant medications, than either an endovascular procedure or surgical bypass procedure may be indicated as a possible therapeutic alternative.
Although long term follow up, greater than 2-5 years, is still being collected for patients who have undergone intracranial balloon angioplasty and/or stenting, the short term results appear to be encouraging in terms of improving symptomatic patient outcomes, and decreasing the risk of major stroke. As continued improvements occur both with optimizing medical therapies, and with technical improvements in the endovascular treatment of these patients, there remains continued hope, that better treatment regimens for intracranial atherosclerotic lesions, will be available to treat these patients.
